Home Cart 0 Sign in  
X

[ CAS No. 705-76-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 705-76-0
Chemical Structure| 705-76-0
Chemical Structure| 705-76-0
Structure of 705-76-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 705-76-0 ]

Related Doc. of [ 705-76-0 ]

Alternatived Products of [ 705-76-0 ]

Product Details of [ 705-76-0 ]

CAS No. :705-76-0 MDL No. :MFCD00004641
Formula : C9H12O3 Boiling Point : -
Linear Structure Formula :- InChI Key :AUDBREYGQOXIFT-UHFFFAOYSA-N
M.W : 168.19 Pubchem ID :69718
Synonyms :

Calculated chemistry of [ 705-76-0 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.33
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 45.55
TPSA : 38.69 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.63 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.24
Log Po/w (XLOGP3) : 0.98
Log Po/w (WLOGP) : 1.04
Log Po/w (MLOGP) : 0.92
Log Po/w (SILICOS-IT) : 1.68
Consensus Log Po/w : 1.37

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.67
Solubility : 3.58 mg/ml ; 0.0213 mol/l
Class : Very soluble
Log S (Ali) : -1.38
Solubility : 7.0 mg/ml ; 0.0416 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.48
Solubility : 0.562 mg/ml ; 0.00334 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.42

Safety of [ 705-76-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 705-76-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 705-76-0 ]
  • Downstream synthetic route of [ 705-76-0 ]

[ 705-76-0 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 705-76-0 ]
  • [ 19179-31-8 ]
YieldReaction ConditionsOperation in experiment
93% With 1,4-diaza-bicyclo[2.2.2]octane; TEMPOL; ammonia; copper(l) chloride In water; acetonitrile at 20℃; for 24 h; General procedure: To a 25-mL Schlenk tube equipped with a magnetic stirrer, CuCl (0.05 mol, 5 molpercent), DABCO (0.10 mol, 10 molpercent), 4-HO-TEMPO (0.05 mmol, 5 molpercent) were added. Substrates 1 (1 mmol) and NH3 (aq, 25-28percent, 3 mmol, 3.0 equiv) in CH3CN (2 mL) were added subsequently. Then the reaction mixture was stirred at room temperature for 24 h in the presence of an air balloon. The progress of the reaction was monitored by TLC. After completion, the reaction mixture was diluted with water and extracted with ethyl acetate. The organic layer was dried over anhydrous MgSO4. Subsequently, the combined organic layer was concentrated under reduced pressure and the crude product was purified by column chromatography to afford the corresponding products.
Reference: [1] Chinese Chemical Letters, 2018, vol. 29, # 3, p. 464 - 466
[2] Applied Organometallic Chemistry, 2018, vol. 32, # 4,
  • 2
  • [ 705-76-0 ]
  • [ 57179-35-8 ]
Reference: [1] Patent: WO2016/14529, 2016, A1,
  • 3
  • [ 705-76-0 ]
  • [ 880-87-5 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1964, vol. 677, p. 21 - 33
  • 4
  • [ 705-76-0 ]
  • [ 13388-75-5 ]
Reference: [1] Advanced Synthesis and Catalysis, 2007, vol. 349, # 4-5, p. 583 - 594
[2] Journal of the American Chemical Society, 2004, vol. 126, # 19, p. 5942 - 5943
[3] Journal of the American Chemical Society, 1948, vol. 70, p. 662
[4] Archiv der Pharmazie, 1972, vol. 305, # 2, p. 124 - 134
[5] Canadian Journal of Chemistry, 1977, vol. 55, # 5, p. 785 - 791
[6] Patent: CN105503652, 2016, A,
  • 5
  • [ 705-76-0 ]
  • [ 61367-62-2 ]
  • [ 74726-76-4 ]
Reference: [1] Australian Journal of Chemistry, 1997, vol. 50, # 8, p. 831 - 840
  • 6
  • [ 705-76-0 ]
  • [ 877-88-3 ]
YieldReaction ConditionsOperation in experiment
100% With phosphorus tribromide In benzene at 20℃; General procedure: benzyl alcohols (1 mmol) in dry benzene (15 mL) and phosphorus tribromides (0.5 mL) and stirred at room temperature to get respective benzyl bromides in quantitative yields, usual work-up.
98% With pyridine; phosphorus tribromide In diethyl ether at 35℃; for 3 h; Inert atmosphere To a solution of 3,5-dimethoxybenzylalcohol (1.5g, 8.918 mmol) in diethyl ether (45mL) under argon atmosphere was added pyridine (0.034mL, 0.445 mmol). Subsequently, phosphorous tribromide (0.83mL, 8.918 mmol) was added dropwise and the resulting reaction mixture was warmed to 35°C and stirred at that temperature for 3h. The reaction mixture was quenched with slow addition of ice-cold water and diluted with ethyl acetate. The aqueous layer was separated and extracted with ethyl acetate (3x30mL). The organic phase was washed with brine, dried over Na2S04, filtered, and concentrated to afford the title compound (2.0g, yield: 98percent) as a white solid. 1H-NMR (D -d6, 300MHz): δ 6.54 (d, 2H), 6.39 (t, 1H), 4.42 (s, 2H), 3.79 (s, 6H).
97% With pyridine; phosphorus tribromide In dichloromethane at 0 - 20℃; for 4 h; PBr3 (18 ml) was added dropwise to a solution of 2 (32.6 g, 194 mmol) and pyridine (0.78 ml) in CH2Cl2 at 0. After the mixture was slowly warmed to room temperature and stirred for 4 h, the reaction was quenched by the slowly addition of ice water, extracted with CH2Cl2, washed with brine, dried over Na2SO4, and concentrated to provide 1-(bromomethyl)-3,5-dimethoxybenzene (3) as white solid ( 43.4g, yield 97percent). 1H NMR (400 MHz, CDCl3) δ 6.54 (s, 2H), 6.39 (s, 1H), 4.42 (s, 2H), 3.79 (s, 6H).
97% With phosphorus tribromide In diethyl ether at 0℃; for 0.5 h; PBr3 (3.10 mL) was addeddrop wise to a solution of (4) 9 g (53.545 mmol) in diethylether at 0 °C. The mixture was stirred at 0 °C for 30 min,and after completion of the reaction (monitored by TLC),the reaction mixture was quenched by slow addition ofpotassium bromide solution, extracted with diethyl ether,washed with brine, dried over Na2SO4 and concentrated toprovide the product (5).1-(Bromomethyl)-3,5-dimethoxybenzene (5) White solid;Yield: 97 percent; mp 68–70 °C;1H NMR (CDCl3, 400 MHz): δ 6.55–6.53 (2H, m, H–2, H–6), 6.40–6.38 (1H, m, H–4),4.42 (2H, s, –CH2–Br), 3.79 (6H, s, 2 X O–CH3); 13C NMR(CDCl3, 75 MHz): δ 161.1 (C, C–3, C–5), 139.7 (C, C–1),106.1 (CH, C–2, C–6), 98.2 (CH, C–4), 55.5 (O–CH3), 30.5(H2C–Br); for C9H11BrO2 MS (ESI) (m/z) 230 [M + H]+.
93% With pyridine; phosphorus tribromide In diethyl ether at 25 - 40℃; for 3 h; NaBH4 (1.11 g, 30.0 mmol, 2.0 equiv) was added slowly to a solution of3, 5-dimethoxybenzaldehyde (2.44 g, 15.0 mmol, 1.0 equiv) inMeOH (30 mL) at 0 0C. After 30 min of stirring at 0 0C, the reaction contents were quenched by the slow addition of water (20 mL) , poured into water (10 mL) , and extracted with EtOAc (3 x 20 mL) . The combined organic layers were then washed with water (20 mL) and brine (20 mL) , dried(MgSO4) , and concentrated to afford the desired alcohol intermediate (2.43 g, 99percent yield) as a white solid which was carried forward without further purification. Next, pyridine (0.017 mL, 0.212 mmol, 0.05 equiv) and PBr3 (0.400 mL, 4.25 mmol, 1.0 equiv) were added sequentially and <n="339"/>slowly to a portion of this newly-formed alcohol (0.715 g, 4.25 mmol, 1.0 equiv) in Et2O (20 inL) at 25 0C, and the resultant mixture was heated at 40 0C for 3 h. Upon completion, the reaction contents were quenched carefully with ice water (15 mL) , poured into water (10 mL) , and extracted with Et2O (3 x 20 mL) . The combined organic layers were then washed with water (15 mL) and brine (15 mL) , dried (MgSO4), and concentrated to afford alkyl halide Sl (1.50 g, 93percent yield) as an amorphous white solid which was carried forward without additional purification. Sl: Rf = 0.66 (silica gel, EtOAc/hexanes, 1:1); IR (film) vraaκ 3002, 2960, 2838, 1597, 1465, 1429, 1348, 1325, 1300, 1264, 1206, 1158, 1064, 992, 931, 836, 693, 650; 1H NMR (300 MHz, CDCl3) δ 6.54 (d, J = 2.1 Hz, 2 H), 6.39 (t, J = 2.1 Hz, 1 H), 4.42 (s, 2 H), 3.80 (s, 6 H); 13C NMR (75 MHz, CDCl3) δ 160.9, 139.7, 107.0 (2 C), 100.6, 55.4 (2 C), 33.6; HRMS (MALDI-FTMS) calculated for C5H11BrO2+ [M+] 229.9942, found 229.9937.
92% With phosphorus tribromide In tetrahydrofuran at -10℃; Phosphorus tribromide (0.4 eq) was added to the alcohol 304 (25 g, 0.13 mol) in THF (100 mL) very slowly at -10° C. and the mixture which resulted was stirred for 15-30 min at the same temperature.
By this time all the starting material had disappeared (TLC).
The reaction mixture was quenched by addition of ice-cold H2O (100 mL) and then filtered through a Buchner funnel.
The filtrate was diluted with brine (100 mL) and extracted with EtOAc (3*300 mL).
The combined organic extracts were dried (Na2S0.4) and concentrated in vacuum.
The crude oil was purified by FCC (20percent ethylacetate in hexane) to afford the bromide 305 as a white solid (92percent)a.: 1HNMR (500 MHz, CDCl3) δ 6.61(2H, d, J=2.3 Hz), 6.46 (1H, t, J=2.3 Hz), 4.5 (2H, s), 3.85 (61-1, s).
13C NMR (125 MHz, CDCl3): δ 161.3, 140.2, 107.4, 101.0, 55.8, 34.1.
The spectral data for 305 were in excellent accord with data previously reported on it (Seidel et al., 1990)1, This material was employed directly in the next step.
85.4% With phosphorus tribromide In dichloromethane at 20℃; Inert atmosphere; Cooling with ice In an ice bath and argon,Was dissolved in 20mL of dry CH2Cl2 4.088g (0.024mol) 3,5- dimethoxybenzene in 100mL methanol 3 neck round bottom flask,Slowly by syringe while stirring was dissolved in 10mL of dichloromethane was added dropwise a solution of 2.54mLPBr3,After 2h the reaction into an ice bath at room temperature,The reaction was continued 2-3h,TLC tracking and detection,The completion of the reaction, etc. The reaction solution was poured into ice water 50mL,Stirring,Lower for the milky white liquid,Plus sodium bicarbonate adjusted to pH 7,After separation of the aqueous layer was extracted with ethyl acetate,Dried over anhydrous sodium sulfate,The solvent was distilled off under reduced pressure,Dried to give compound 4The yield was 85.4percent,
78% With 1H-imidazole; bromine; triphenylphosphine In dichloromethane at 0 - 20℃; for 24 h; To a dry 250 mL rbf charged with 125 mL dry CH2Cl2 cooled to 0 °C was added in order, PPh3 (7.59 g, 28.9 mmol, 1.2 eq.), imidazole (1.97 g, 28.9 mmol, 1.2 eq.), Br2 (1.50 mL, 28.9 mmol, 1.2 eq.) and 3,5-dimethoxybenzyl alcohol (4.06 g, 24.1 mmol, 1.0 eq.). The reaction was stirred at r.t. for 24 h. Workup provided 3,5-dimethoxybenzyl bromide (4.35 g, 78percent) as a colourless oil.

Reference: [1] Journal of Steroid Biochemistry and Molecular Biology, 2013, vol. 137, p. 332 - 344
[2] Journal of Asian Natural Products Research, 2011, vol. 13, # 4, p. 290 - 296
[3] Patent: WO2016/164703, 2016, A1, . Location in patent: Page/Page column 41
[4] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 24, p. 7683 - 7687
[5] Medicinal Chemistry Research, 2016, vol. 25, # 4, p. 627 - 643
[6] MedChemComm, 2014, vol. 5, # 5, p. 609 - 616
[7] Tetrahedron Letters, 1996, vol. 37, # 29, p. 5171 - 5174
[8] Organic and Biomolecular Chemistry, 2016, vol. 14, # 4, p. 1382 - 1394
[9] Journal of Labelled Compounds and Radiopharmaceuticals, 2004, vol. 47, # 3, p. 167 - 174
[10] Angewandte Chemie - International Edition, 2007, vol. 46, # 43, p. 8186 - 8191
[11] Patent: WO2009/38731, 2009, A2, . Location in patent: Page/Page column 337-338
[12] Synlett, 2013, vol. 24, # 9, p. 1109 - 1112
[13] Marine Drugs, 2012, vol. 10, # 5, p. 1103 - 1125
[14] Patent: US2017/342047, 2017, A1, . Location in patent: Paragraph 0179-0180
[15] Journal of Medicinal Chemistry, 2002, vol. 45, # 12, p. 2534 - 2542
[16] Journal of the Chemical Society - Perkin Transactions 1, 1996, # 21, p. 2603 - 2613
[17] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2016, vol. 55B, # 8, p. 1035 - 1038
[18] Advanced Synthesis and Catalysis, 2007, vol. 349, # 4-5, p. 583 - 594
[19] Patent: CN105503652, 2016, A, . Location in patent: Paragraph 0046; 0047
[20] Tetrahedron Letters, 1996, vol. 37, # 8, p. 1191 - 1194
[21] Tetrahedron, 2011, vol. 67, # 5, p. 1002 - 1010
[22] Chemical Communications, 2011, vol. 47, # 23, p. 6713 - 6715
[23] Journal of the American Chemical Society, 1996, vol. 118, # 18, p. 4354 - 4360
[24] Journal of Organic Chemistry, 2000, vol. 65, # 15, p. 4698 - 4705
[25] Helvetica Chimica Acta, 1969, vol. 52, # 4, p. 1102 - 1134
[26] Justus Liebigs Annalen der Chemie, 1964, vol. 677, p. 21 - 33
[27] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1980, p. 87 - 90
[28] Tetrahedron, 1981, vol. 37, # 23, p. 3977 - 3980
[29] Chemistry and Physics of Lipids, 1994, vol. 71, # 2, p. 229 - 243
[30] Life Sciences, 1995, vol. 56, # 23/24, p. 2013 - 2020
[31] Medicinal Chemistry Research, 2002, vol. 11, # 2, p. 116 - 136
[32] Journal of the American Chemical Society, 1992, vol. 114, # 11, p. 4230 - 4237
[33] Patent: US5547967, 1996, A,
[34] Journal of the American Chemical Society, [35] Journal of the American Chemical Society, 2009, vol. 131, p. 1753 - 1765
[36] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 14, p. 5352 - 5366
[37] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 18, p. 5971 - 5975
[38] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 13, p. 3465 - 3477
[39] Asian Journal of Chemistry, 2014, vol. 26, # 7, p. 2092 - 2098
[40] Organic and Biomolecular Chemistry, 2015, vol. 13, # 17, p. 4879 - 4895
[41] RSC Advances, 2015, vol. 5, # 100, p. 82153 - 82158
[42] PLoS ONE, 2015, vol. 10, # 10,
[43] European Journal of Medicinal Chemistry, 2017, vol. 126, p. 36 - 51
[44] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 13, p. 3285 - 3297
[45] MedChemComm, 2018, vol. 9, # 11, p. 1862 - 1870
  • 7
  • [ 705-76-0 ]
  • [ 4670-09-1 ]
Reference: [1] Archiv der Pharmazie, 1972, vol. 305, # 2, p. 124 - 134
  • 8
  • [ 705-76-0 ]
  • [ 22972-63-0 ]
Reference: [1] Journal of the American Chemical Society, 1948, vol. 70, p. 662
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 705-76-0 ]

Aryls

Chemical Structure| 6971-51-3

[ 6971-51-3 ]

(3-Methoxyphenyl)methanol

Similarity: 0.97

Chemical Structure| 119650-44-1

[ 119650-44-1 ]

(3-Methoxy-5-methylphenyl)methanol

Similarity: 0.97

Chemical Structure| 105-13-5

[ 105-13-5 ]

(4-Methoxyphenyl)methanol

Similarity: 0.94

Chemical Structure| 93-03-8

[ 93-03-8 ]

(3,4-Dimethoxyphenyl)methanol

Similarity: 0.91

Chemical Structure| 33626-08-3

[ 33626-08-3 ]

(E)-5-(4-Methoxystyryl)benzene-1,3-diol

Similarity: 0.91

Ethers

Chemical Structure| 6971-51-3

[ 6971-51-3 ]

(3-Methoxyphenyl)methanol

Similarity: 0.97

Chemical Structure| 119650-44-1

[ 119650-44-1 ]

(3-Methoxy-5-methylphenyl)methanol

Similarity: 0.97

Chemical Structure| 105-13-5

[ 105-13-5 ]

(4-Methoxyphenyl)methanol

Similarity: 0.94

Chemical Structure| 93-03-8

[ 93-03-8 ]

(3,4-Dimethoxyphenyl)methanol

Similarity: 0.91

Chemical Structure| 33626-08-3

[ 33626-08-3 ]

(E)-5-(4-Methoxystyryl)benzene-1,3-diol

Similarity: 0.91

Alcohols

Chemical Structure| 6971-51-3

[ 6971-51-3 ]

(3-Methoxyphenyl)methanol

Similarity: 0.97

Chemical Structure| 119650-44-1

[ 119650-44-1 ]

(3-Methoxy-5-methylphenyl)methanol

Similarity: 0.97

Chemical Structure| 105-13-5

[ 105-13-5 ]

(4-Methoxyphenyl)methanol

Similarity: 0.94

Chemical Structure| 93-03-8

[ 93-03-8 ]

(3,4-Dimethoxyphenyl)methanol

Similarity: 0.91

Chemical Structure| 119138-29-3

[ 119138-29-3 ]

4-(Hydroxymethyl)-3-methoxyphenol

Similarity: 0.89